ERCC4 associated with breast cancer risk: A two-stage case-control study using high-throughput genotyping

Cancer Research

Volumn 66, Issue 19, 2006, Pages 9420-9427

  Milne, Roger Laughlin ^a   Ribas, Gloria ^a   González Neira, Anna ^a   Fagerholm, Rainer ^b   Salas, Antonio ^c   González, Emilio ^a   Dopazo, Joaquín ^d   Nevanlinna, Heli ^b   Robledo, Mercedes ^a   Benítez, Javier ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FINLAND; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; FINLAND; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SPAIN;

EID: 33750295358     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1418     Document Type: Article

References (57)

1. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
2. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003;33 Suppl:228-37.
3. Houlston RS, Peto J. The search for low-penetrance cancer susceptibility alleles. Oncogene 2004;23:6471-6.
4. Pharoah PD, Dunning AM, Ponder BA, Easton DF. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004;4:850-60.
5. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004;5:89-100.
6. Wang WY, Barratt BJ, Clayton DG, Todd JA. Genomewide association studies: theoretical and practical concerns. Nat Rev Genet 2005;6:109-18.
7. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:33-6.
8. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 2004;429:446-52.
9. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
10. Daimon M, Ji G, Saitoh T, et al. Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population. Biochem Biophys Res Commun 2003;302:751-8.
11. Hao K, Wang X, Niu T, et al. A candidate gene association study on preterm delivery: application of high-throughput genotyping technology and advanced statistical methods. Hum Mol Genet 2004;13:683-91.
12. Kammerer S, Roth RB, Reneland R, et al. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res 2004;64:8906-10.
13. Hu N, Wang C, Hu Y, et al. Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res 2005;65:2542-6.
14. Li Y, Nowotny P, Holmans P, et al. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci U S A 2004;101:15688-93.
15. Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP. Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry 2004;9:879-89.
16. Ozaki K, Tanaka T. Genome-wide association study to identify SNPs conferring risk of myocardial infarction and their functional analyses. Cell Mol Life Sci 2005;62:1804-13.
17. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004;75:353-62.
18. Shiffman D, Ellis SG, Rowland CM, et al. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 2005;77:596-605.
19. Cox DG, Hankinson SE, Hunter DJ. Polymorphisms in the ICAM gene locus are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:178-9.
20. Thompson D, Easton D. The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 2004;9:221-36.
21. Diez O, Osorio A, Duran M, et al. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 2003;22:301-12.
22. Houlston RS, Peto J. The future of association studies of common cancers. Hum Genet 2003;112:434-5.
23. Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 2003;25:190-202.
24. Osorio A, Barroso A, Martinez B, et al. Molecular analysis of the BRCA1 and HRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer 2000;82:1266-70.
25. Kilpivaara O, Bartkova J, Eerola H, et al. Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients. Int J Cancer 2005;113:575-80.
26. Syrjakoski K, Vahteristo P, Eerola H, et al. Population-based study of BRCA1 and HRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 2000;92:1529-31.
27. Vahteristo P, Eerola H, Lamminen A, Blomqvist C, Nevanlinna H. A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer 2001;84:704-8.
28. Vehmanen P, Friedman LS, Eerola H, et al. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 1997;6:2309-15.
29. The International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-96.
30. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
31. Conde L, Vaquerizas JM, Santoyo J, et al. PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res 2004;32:W242-8.
32. Ovcharenko I, Nobrega MA, Loots GG, Stubbs L. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 2004;32:W280-6.
33. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques 2002;33 Suppl:56-8, 60-1.
34. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P. Association mapping in structured populations. Am J Hum Genet 2000;67:170-81.
35. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999;65:220-8.
36. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000;155:945-59.
37. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003;164:1567-87.
38. Li J, Li L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005;95:221-7.
39. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004;74:765-9.
40. Nyholt DR. Evaluation of Nyholt's procedure for multiple testing correction [author's reply]. Hum Hered 2005;60:61-2.
41. StataCorp. Stat Statistical Software: Release 8.0. In: College Station (TX): Stata Corporation: 2003.
42. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-84.
43. Ribas G, Gonzalez-Neira A, Salas A, et al. Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes. Hum Genet 2006;118:669-79.
44. Mechanic LE, Millikan RC, Plaver J, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 2006;27:1377-85.
45. Smith TR, Levine EA, Perrier ND, et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:1200-4.
46. Zhang J, Rowe WL, Clark AG, Buetow KH. Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations. Am J Hum Genet 2003;73:1073-81.
47. Hoyal CR, Kammerer S, Roth RB, et al. Genetic polymorphisms in DPF3 associated with risk of breast cancer and lymph node metastases. J Carcinog 2005;4:13.
48. Kammerer S, Roth RB, Hoyal CR, et al. Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility. Proc Natl Acad Sci U S A 2005;102:2004-9.
49. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 2003;12:1489-98.
50. Kornguth DG, Garden AS, Zheng Y, Dahlstrom KR, Wei Q, Sturgis EM. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys 2005;62:665-71.
51. Lee SA, Lee KM, Park WY, et al. Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer. Exp Mol Med 2005;37:86-90.
52. Drake JA, Bird C, Nemesh J, et al. Conserved noncoding sequences are selectively constrained and not mutation cold spots. Nat Genet 2006;38:223-7.
53. Tokuhiro S, Yamada R, Chang X, et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003;35:341-8.
54. Naukkarinen J, Gentile M, Soro-Paavonen A, et al. USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet 2005;14:2595-605.
55. Dean G, Clark IM. Transcriptional regulation of the human tissue inhibitor of metalloproteinases-1: mapping transcriptional control in intron-1. Ann N Y Acad Sci 1999;878:510-1.
56. Kawada N, Moriyama T, Ando A, et al. Role of intron 1 in smooth muscle α-actin transcriptional regulation in activated mesangial cells in vivo. Kidney Int 1999;55:2338-48.
57. Beohar N, Kawamoto S. Transcriptional regulation of the human nonmuscle myosin II heavy chain-A gene. Identification of three clustered cis-elements in intron-1 which modulate transcription in a cell type- and differentiation state-dependent manner. J Biol Chem 1998;273:9168-78.